Association of .beta.2-adrenergic receptor haplotypes with drug response
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 1, 2003
Grant Date -
Dec 13, 2001
app pub date -
Mar 16, 2001
filing date -
Apr 13, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Genotypes and haplotypes for thirteen polymorphic sites in the .beta..sub.2 -adrenergic receptor (.beta..sub.2 AR) gene are disclosed. Compositions and methods for predicting genetic predisposition to disease associated with polymorphic sites in the (.beta..sub.2 AR) gene, as well as for predicting response to .beta.-agonists, are also disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully